Retraction to: Extranuclear ERα is associated with regression of T47D PKCα-overexpressing, tamoxifen-resistant breast cancer. [Mol Cancer. 12, (2013) (34)] DOI: 10.1186/1476-4598-12-34

Bethany Perez White; Mary Ellen Molloy; Huiping Zhao; Yiyun Zhang; Debra A. Tonetti

doi:10.1186/s12943-017-0697-5

Retraction to: Extranuclear ERα is associated with regression of T47D PKCα-overexpressing, tamoxifen-resistant breast cancer. [Mol Cancer. 12, (2013) (34)] DOI: 10.1186/1476-4598-12-34

Bethany Perez White, Mary Ellen Molloy, Huiping Zhao, Yiyun Zhang, Debra A. Tonetti^*

^*Corresponding author for this work

Dermatology

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

This article [1] has been retracted by the authors after they discovered an error in the data. The authors recently performed Short Tandem Repeat (STR) analysis on all of their cell lines and discovered that the cell clone T47D:A18/PKCa is in fact MCF-7/PKCa. They have verified this using next generation sequencing of the p53 mutation that is a hallmark of T47D cells. All other cell lines reported in this article are as originally described. As a result of this error, parts of the article are inaccurate which affects the article's conclusions. The authors will be given the opportunity to resubmit their corrected data.

Original language	English (US)
Article number	121
Journal	Molecular Cancer
Volume	16
Issue number	1
DOIs	https://doi.org/10.1186/s12943-017-0697-5
State	Published - Jul 17 2017

ASJC Scopus subject areas

Molecular Medicine
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1186/s12943-017-0697-5

Cite this

@article{25f298ca70634331a4b416f868c3532e,

title = "Retraction to: Extranuclear ERα is associated with regression of T47D PKCα-overexpressing, tamoxifen-resistant breast cancer. [Mol Cancer. 12, (2013) (34)] DOI: 10.1186/1476-4598-12-34",

abstract = "This article [1] has been retracted by the authors after they discovered an error in the data. The authors recently performed Short Tandem Repeat (STR) analysis on all of their cell lines and discovered that the cell clone T47D:A18/PKCa is in fact MCF-7/PKCa. They have verified this using next generation sequencing of the p53 mutation that is a hallmark of T47D cells. All other cell lines reported in this article are as originally described. As a result of this error, parts of the article are inaccurate which affects the article's conclusions. The authors will be given the opportunity to resubmit their corrected data.",

author = "White, {Bethany Perez} and Molloy, {Mary Ellen} and Huiping Zhao and Yiyun Zhang and Tonetti, {Debra A.}",

note = "Publisher Copyright: {\textcopyright} The Author(s).",

year = "2017",

month = jul,

day = "17",

doi = "10.1186/s12943-017-0697-5",

language = "English (US)",

volume = "16",

journal = "Molecular Cancer",

issn = "1476-4598",

publisher = "BioMed Central",

number = "1",

}

Retraction to: Extranuclear ERα is associated with regression of T47D PKCα-overexpressing, tamoxifen-resistant breast cancer. [Mol Cancer. 12, (2013) (34)] DOI: 10.1186/1476-4598-12-34. / White, Bethany Perez; Molloy, Mary Ellen; Zhao, Huiping et al.
In: Molecular Cancer, Vol. 16, No. 1, 121, 17.07.2017.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Retraction to

T2 - Extranuclear ERα is associated with regression of T47D PKCα-overexpressing, tamoxifen-resistant breast cancer. [Mol Cancer. 12, (2013) (34)] DOI: 10.1186/1476-4598-12-34

AU - White, Bethany Perez

AU - Molloy, Mary Ellen

AU - Zhao, Huiping

AU - Zhang, Yiyun

AU - Tonetti, Debra A.

PY - 2017/7/17

Y1 - 2017/7/17

N2 - This article [1] has been retracted by the authors after they discovered an error in the data. The authors recently performed Short Tandem Repeat (STR) analysis on all of their cell lines and discovered that the cell clone T47D:A18/PKCa is in fact MCF-7/PKCa. They have verified this using next generation sequencing of the p53 mutation that is a hallmark of T47D cells. All other cell lines reported in this article are as originally described. As a result of this error, parts of the article are inaccurate which affects the article's conclusions. The authors will be given the opportunity to resubmit their corrected data.

AB - This article [1] has been retracted by the authors after they discovered an error in the data. The authors recently performed Short Tandem Repeat (STR) analysis on all of their cell lines and discovered that the cell clone T47D:A18/PKCa is in fact MCF-7/PKCa. They have verified this using next generation sequencing of the p53 mutation that is a hallmark of T47D cells. All other cell lines reported in this article are as originally described. As a result of this error, parts of the article are inaccurate which affects the article's conclusions. The authors will be given the opportunity to resubmit their corrected data.

UR - http://www.scopus.com/inward/record.url?scp=85023767081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85023767081&partnerID=8YFLogxK

U2 - 10.1186/s12943-017-0697-5

DO - 10.1186/s12943-017-0697-5

M3 - Comment/debate

C2 - 28716023

AN - SCOPUS:85023767081

SN - 1476-4598

VL - 16

JO - Molecular Cancer

JF - Molecular Cancer

IS - 1

M1 - 121

ER -

Retraction to: Extranuclear ERα is associated with regression of T47D PKCα-overexpressing, tamoxifen-resistant breast cancer. [Mol Cancer. 12, (2013) (34)] DOI: 10.1186/1476-4598-12-34

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this